Continuous And Data-drivEN CarE (CADENCE) Pilot (NCT05609669)
Continuous And Data-drivEN CarE (CADENCE)
🩺 Plain-English Summary (8th-Grade Level)
The proposed project seeks to use public health and clinical data on opioid use disorders (OUD) outcomes for mother and infants, which is the leading cause of death to mothers one year after deliver and can lead to neonatal withdrawal syndrome (NOWS) and other poor outcomes. Insufficient or incomplete data about OUD and lack of integrated programs for OUD treatment during pregnancy can be barriers to providing optimal care to mothers and infants.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (1 items) and avoid the listed exclusions (2 items).
Location: University of South Florida/Tampa General Hospital — Tampa, Florida
Age range: 18 Years
🧪 Interventions in This Study
- CADENCE program (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patients without opioid use disorder, less than 18 years old, incarcerated, or non-pregnant
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- University of South Florida/Tampa General Hospital — Tampa, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pregnancy Related
- Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE — Milwaukee, Wisconsin
- Trial of Community-based Patient Navigation — Atlanta, Georgia
- Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population — Morrisville, North Carolina
- Impact of Lactation Antenatal Teaching by Clinicians and Healthcare Providers — Loma Linda, California
- PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism — Durham, North Carolina
- Natural Versus Programmed Frozen Embryo Transfer (NatPro) — San Francisco, California
Explore by condition: All Pregnancy Related clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.